Linked In Blog - Sedgwick
Skip to content

Posts related to ‘brand protection and recall’

Search
Filter
View
Blog
November 08, 2022
Guest author: Will Troutman
Spotlight: ESG and product compliance

Foreword by Chris Harvey, SVP client services at Sedgwick: Welcome to the latest edition of spotlight. Spotlight is our way of sharing insight and perspective from our strategic partners across industries on safety issues that have the potential to …

November 08, 2022 by Guest author: Will Troutman
Blog
October 31, 2022
Chris Harvey
VP, crisis solution
The spooky side of recalls

It’s the time of year, the spooky atmosphere of Halloween is in the air. And while ghosts, vampires and monsters are creepy enough, there’s one thing that can truly send a chill up your spine — poorly managed recalls. Regardless of whethe…

October 31, 2022 by Chris Harvey, VP, crisis solution
Blog
October 13, 2022
Guest author: David Kidman
Spotlight: Supply chain claims in product recalls: Maximize your recovery of losses

Foreword by Julie Ross, international business development director at Sedgwick: Welcome to the latest edition of Spotlight. Spotlight is our way of sharing insights and perspectives from our strategic partners – lawyers, insurers, risk managers and…

October 13, 2022 by Guest author: David Kidman
Blog
October 12, 2022
Mark Buckingham
recall advisor
EU still at work on draft proposal to overhaul pharmaceuticals law

Reports indicate that the European Commission’s proposed overhaul of the EU’s general legislation on medicines for human use was rejected by the Regulatory Scrutiny Board, sending it back to the Commission for revision. The Commission was originally…

October 12, 2022 by Mark Buckingham, recall advisor
Blog
October 10, 2022
Ryan Gooley
New FDA report sheds light on infant formula crisis

The Food and Drug Administration (FDA) came under harsh criticism this past year after a commercial infant shortage formula in the U.S. For months, Congress and parent advocacy groups have been pressuring the agency to investigate why this crisis eru…

October 10, 2022 by Ryan Gooley
Blog
October 04, 2022
Chris Harvey
VP, crisis solution
What does post-pandemic look like? More oversight all around

The COVID-19 pandemic has changed the business world in numerous ways. Virtual meetings, remote work schedules, travel restrictions, and supply chain volatility are just a few examples of the new reality we’ll inevitably face ongoing. To that list yo…

October 04, 2022 by Chris Harvey, VP, crisis solution
Blog
September 16, 2022
Chris Harvey
VP, crisis solution
U.S. surpasses milestone of 1 billion product recalls year to date

The total number of U.S. products recalled this year has now topped 1 billion, according to our latest U.S. product Recall Index. More than 1 billion units have been recalled only twice before in history, in 2018 and 2021. However, it took a full yea…

September 16, 2022 by Chris Harvey, VP, crisis solution
Blog
June 28, 2022
Chris Occleshaw
recall consultant
European recalls decline 2.4% overall in the first quarter of 2022

Even as many countries eased pandemic-related restrictions, recent events have introduced a new host of challenges and risks for the five key industries surveyed in our latest edition of the European Recall Index report. Our report includes analysis …

June 28, 2022 by Chris Occleshaw, recall consultant
Blog
June 24, 2022
Chris Harvey
VP, crisis solution
More than 900 million units recalled in the US as enforcement activity picks up

More than 900 million units of vehicles, food, drugs, consumer products and medical devices were recalled during the first quarter of 2022. This is the highest number recalled in a single quarter over the past 10 years, as reported in our latest edit…

June 24, 2022 by Chris Harvey, VP, crisis solution
Blog
June 06, 2022
Chris Occleshaw
recall consultant
Food safety priorities for the coming year

With an increase of food-related product recalls in the European Union and United Kingdom in the past few years, food safety has become an increasingly relevant topic worldwide. Consumers and regulators are paying closer attention to food safety and …

June 06, 2022 by Chris Occleshaw, recall consultant
Blog
May 09, 2022
Julie Ross
International business development director
New CMR substance bans create consequences for the cosmetics industry

The European Commission now seems to routinely extend the list of carcinogenic, mutagenic, or reprotoxic (“CMR”) substances that are prohibited for use in cosmetics throughout the EU. Most of these banned substances are relatively unknown, but a grow…

May 09, 2022 by Julie Ross, International business development director
Blog
May 05, 2022
Guest author: Nicola Smith
Spotlight: The scope of food safety is expanding in the EU and the UK

Foreword by Julie Ross, international business development director at Sedgwick: Welcome to the latest edition of spotlight. Spotlight is our way of sharing insights and perspectives from our strategic partners – lawyers, insurers, risk managers and…

May 05, 2022 by Guest author: Nicola Smith
Blog
April 27, 2022
Jeremy Schutz
Rise in deaths linked to children’s products renews push for safety disclosure law

Following a steady increase in reported deaths caused by faulty children’s products, the Consumer Product Safety Commission (CPSC) is under pressure to act more aggressively in pushing companies to recall products that pose a risk to children and tod…

April 27, 2022 by Jeremy Schutz
Blog
April 20, 2022
Guest author: Nicola Smith
Spotlight: What’s driving the increase in food recalls in the EU?

Foreword by Julie Ross, international business development director at Sedgwick: Welcome to the latest edition of spotlight. Spotlight is our way of sharing insights and perspectives from our strategic partners – lawyers, insurers, risk managers and…

April 20, 2022 by Guest author: Nicola Smith
Blog
April 18, 2022
Ryan Gooley
With the FDA’s latest recall guidance, mock recalls are now a must

As COVID-19 begins to subside, the U.S. Food and Drug Administration (FDA), like other federal agencies is shifting its focus away from the pandemic and back toward more routine issues. As an example, the FDA recently published its final guidance out…

April 18, 2022 by Ryan Gooley
Load more
End of results.
Loading...